Form D · Pharmaceuticals
NuPotential, Inc.
Baton Rouge, LA · CIK 0001567790
Offering snapshot reported Mar 5, 2014 · SEC filing
- Reported sold
- $375K Offering amount: $375K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 21, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 5, 2014 | Initial | $375,000 | No comparison | 5 | SEC filing |
| Mar 7, 2013 | Amendment | $350,000 | $140,000vs Jan 29, 2013 | 2 | SEC filing |
| Jan 29, 2013 | Initial | $210,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212975
Source: Form D, filed Mar 5, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ross Barrett | Director |
| Kenneth J Eilertsen | Director |
| Joseph F Lovett | Director, Executive |
| Joan P Neuscheler | Director, Executive |
| Charles Oehler | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
East Parker Boulevard, Lsu Campus Building #340
Baton Rouge, LA, 70803
Baton Rouge, LA, 70803